1. Five drugs, including two from Novartis, win EMA endorsement —What’s next for Amarin’s stock after FDA panel recommendation — Shionogi antibiotic scores FDA ok— See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Are we buying Otezla?

Discussion in 'Galderma' started by anonymous, Jun 24, 2019 at 5:28 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Bristol has to spin it off to make their merger work
     
  2. anonymous

    anonymous Guest

    What’s the last billion dollar drug we’ve purchased? Nothing. You think a PE firm is going to spend billions on a drug after they’re spending 10.2B for us already?
     
  3. anonymous

    anonymous Guest

    Otezla would cost us more than we are worth! The early bets are in the 9-11 billion range.
     
  4. anonymous

    anonymous Guest

    No